|
|
||||||||
Original Report |
1
Department of Radiology and the Institute of Radiation Medicine, Seoul
National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744
Seoul, Korea.
2
Department of Surgery, Seoul National University College of Medicine,
Chongno-gu, 110-744 Seoul, Korea.
Received November 9, 1999;
accepted after revision January 10, 2000.
Address correspondence to J. K. Han
Abstract
|
|
|---|
CONCLUSION. Segmental or lobar dilatation of the intrahepatic bile ducts associated with or without intraductal polypoid mass, amorphous structures, or both with slight hyperattenuation are common CT findings of intraductal intrahepatic cholangiocarcinoma. The size of the intraductal mass determines the visibility on CT.
|
|
|---|
There have been many reports about the radiologic appearance of intrahepatic cholangiocarcinoma; however, the reports have mainly focused on the more common massforming type [1, 2, 8]. To our knowledge, the radiologic appearances of intraductal intrahepatic cholangiocarcinomas have not yet been described. The purpose of our study was to describe the CT features of intraductal intrahepatic cholangiocarcinoma and to correlate them with pathologic features.
|
|
|---|
Imaging Methods
Of 16 patients, CT was performed in 15 and cholangiography in 12
(percutaneous transhepatic cholangiography in 10 and ERCP in two). The time
interval between CT and surgery ranged from 15 to 190 days (mean, 34.5 days).
Helical CT was performed in eight patients and conventional CT in seven.
Helical CT was performed with one of three scanners (HiSpeed, General Electric
Medical Systems, Milwaukee, WI; and Somatom Plus-S or Somatom Plus-4, Siemens
Medical Systems, Erlangen, Germany). Each patient received 100 mL or 120 mL of
iopromide (Ultravist 300; Schering, Berlin, Germany) or iopamidol (Iopamiro
300; Bracco, Milan, Italy), which was injected into the antecubital vein
through an 18-gauge cannula at a rate of 3 mL/sec. Helical CT parameters
included a 20-sec acquisition time; 5-, 7-, or 10-mm collimation; and a 1:1 or
2:1 table pitch. Helical CT was performed 30 and 65 sec after the initiation
of injection (arterial and portal venous phases, respectively). Images were
reconstructed every 5, 7, or 10 mm. In conventional CT, incremental scans were
obtained after manual injection of 100 mL of various contrast materials
administered at about 2 mL/sec, with scanning begun 40-60 sec after initiation
of the bolus of contrast material. Contiguous 10-mm axial sections were
usually obtained with single scans and short interscan delays for patient
breathing and table motion. An average of 3-4 min was needed to cover the
liver.
Image Analysis
CT features were retrospectively reviewed with to particular attention to
the location (segmental or lobar), degree (mild or marked [larger than 15 mm
in diameter]) of the intrahepatic bile duct dilatation, attenuation within the
dilated bile duct, the presence and attenuation of intraductal polypoid mass,
and associated findings such as biliary calculi, ascites, lymphadenopathy, or
distant metastasis. Four radiologists reviewed the findings. CT scans were
evaluated in one session and interpreted by consensus. After the evaluation of
images, radiologists discussed the findings with two surgeons to correlate
imaging features with gross appearances.
|
|
|---|
|
|
|
Intraductal masses were revealed on CT in eight patients (53.3%). The masses were seen as multiple intraductal papillary tumors within the markedly dilated ducts in two patients (Fig. 1A,1B,1C) and a single mass measuring 1-4 cm in the distal end of the dilated ducts with mild dilatation of the peripheral ducts in six (Figs. 2A,2B and 3). The masses had slightly lower attenuation than the hepatic parenchyma on both enhanced conventional CT and helical CT (during both arterial and portal phases) (Figs. 1A,1B,1C,2A,2B,3). In seven patients (46.6%), the intraductal mass was not found on CT (Figs. 4 and 5A,5B,5C).
|
|
|
|
|
|
|
In seven patients (46.6%), some parts of the dilated ducts showed slight hyperattenuation on CT compared with other parts of the dilated ducts or the lumen of the gallbladder (Figs. 3 and 6A,6B). An intraductal mass in the distal ends of the dilated duct was seen in three of these seven patients.
|
|
Intrahepatic bile duct stones were seen in two patients and gallbladder stones in two others. No abdominal lymph node enlargement, ascites, or distant metastasis was found.
CT-Pathology Correlation
We grouped the CT findings of the 15 patients who underwent CT into five
subtypes according to the degree of bile duct dilatation, attenuation of
dilated duct, and presence of intraductal mass. We correlated these five
subtypes of CT findings with pathology.
In type 1 (n = 3; intrahepatic bile duct dilatation only on CT [Figs. 4 and 5A,5B,5C]), gross pathology revealed a single small (<1 cm) intraductal mass in the dilated duct (n = 2). In one patient, an intraductal mass with tumor casts plugged into the peripheral duct was noted; however, the time interval between CT examination and the surgery was 190 days in this patient (Fig. 3).
In type 2 (n = 3; detectable mass in distal end of dilated intrahepatic bile ducts without hyperattenuation on CT [Fig. 2A,2B]), a single intraductal mass was present in large ducts. The size of the mass found in each of the three patients was 1.5, 1.5, and 2 cm. No tumor casts were found in the peripheral ducts at pathology.
In type 3 (n = 4; hyperattenuation of dilated ducts without demonstrable mass on CT [Fig. 6A,6B]), the surgical specimen revealed numerous small papillary tumors spreading along the wall of the bile duct. Peripheral ducts were filled with tumor cell casts and small papillary tumors.
In type 4 (n = 3; a detectable mass in the distal end of the dilated bile ducts with hyperattenuation on CT [Fig. 3]), a large polypoid mass (2.5, 2, and 4 cm in the three patients) with superficially spreading masses and tumor casts plugging peripheral dilated ducts was noted.
In type 5 (n = 2; papillary intraductal tumors with markedly dilated ducts on CT [Fig. 1A,1B,1C]), intrahepatic bile ducts were filled with a large amount of mucin at pathology. Thick mucinous fluid retained within the duct caused marked ductal dilatation. In one patient, distal common bile duct was also dilated as a result of intraductal mucin.
At microscopic examination, all patients had papillary adenocarcinomas except two (one with papillotubular and one with intestinal type). The worm of Clonorchis sinensis was found in four patients, and intrahepatic stones were found in four others. In two, the intrahepatic bile duct stones were too small to be imaged on radiologic studies.
|
|
|---|
In our study, CT findings of intraductal intrahepatic cholangiocarcinoma
can be grouped into five categories. The degree of ductal dilatation was
determined by the presence of mucin. In tumors that excrete excessive amounts
of mucin into the bile duct, the accumulated mucin caused significant ductal
dilatation distal as well as proximal to the tumor. Detection of the
obstructing mass on CT depends on the size of the tumor. CT could not depict
tumors smaller than 1 cm, whereas all tumors larger than 1 cm could be
detected on CT. Therefore, a careful trace of the dilated duct is essential in
depicting the obstructing mass. The attenuation of the tumor was slightly
lower than that of the hepatic parenchyma, even on good quality two-phase
helical CT. According to previous reports, cholangiocarcinomas tend to have
increased contrast enhancement on delayed CT scans
[11,12].
However, in our study, this enhancement pattern was not seen. Intraductal
papillary tumors do not have fibrotic stroma, which is the cause of delayed
enhancement in classic peripheral cholangiocarcinomas. The attenuation of the
dilated duct was determined by the presence of tumor casts or diffuse
spreading of the papillary tumor itself. Although the hyperattenuation of the
dilated ducts is a valuable clue that can lead to correct diagnosis, there are
some conditions that can have the same finding. Focal stricture with
subsequent cholangitis in dilated ducts can cause hyperattenuation of the duct
caused by inflammatory cells and necrotic material. Partial volume-averaging
artifact can also cause some hyperattenuation of ducts; however,
hyperattenuation is not seen within ducts running perpendicular to the CT
plane. Another possible diagnosis is the biliary invasion of the
hepatocellular carcinoma. Presence of radiologic features of chronic liver
disease, elevated levels of
-fetoprotein, and the hypervascular nature
of the tumor might be clues to the correct diagnosis.
After curative surgery, the prognosis was good in our series (15 survivors out of 16 patients; 36.1 months of mean follow-up) as in previous reports [4,5,6,7, 9]. Because surgical resection can be curative, early and accurate diagnosis is important in this disease. When we find lobar or segmental ductal dilatation, especially with higher attenuation on CT, careful trace of the bile duct to find any obstructing lesion is mandatory. Although CT plays an important role in differentiating the cause of ductal dilatation, it still has limitations in detecting small tumors or differentiating tumor casts from bile sludge or "muddy" stones. In these cases, direct cholangiography and bile cytology would be diagnostic. Because this type of tumor tends to have diffuse superficial spreading along the ductal surface (10/16, 62.5% in our series) [4,5,6,7, 9], accurate preoperative mapping of the tumor is necessary before planning surgical resection. Even the state-of-the-art percutaneous transhepatic cholangiogram cannot depict the true extent of the tumor in some instances. Choledochoscopy-guided biopsy might be needed to know the exact extent of the tumor [4,5, 7].
In conclusion, segmental or lobar dilatation of intrahepatic bile ducts with higher attenuation is the characteristic CT finding in intraductal intrahepatic cholangiocarcinomas. The obstructing mass larger than 1 cm can be depicted as a low-attenuation mass in the distal end of dilated ducts on CT.
|
|
|---|
This article has been cited by other articles:
![]() |
Y. J. Lee, S. H. Kim, J. Y. Lee, M. A Kim, J. M. Lee, J. K. Han, and B. I. Choi Differential CT Features of Intraductal Biliary Metastasis and Double Primary Intraductal Polypoid Cholangiocarcinoma in Patients With a History of Extrabiliary Malignancy Am. J. Roentgenol., October 1, 2009; 193(4): 1061 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. E. Chung, M.-J. Kim, Y. N. Park, J.-Y. Choi, J. Y. Pyo, Y. C. Kim, H. J. Cho, K. A. Kim, and S. Y. Choi Varying Appearances of Cholangiocarcinoma: Radiologic-Pathologic Correlation1 RadioGraphics, May 1, 2009; 29(3): 683 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
Answer Gut, October 1, 2006; 55(10): 1439 - 1439. [Full Text] [PDF] |
||||
![]() |
J. M. Slattery and D. V. Sahani What Is the Current State-of-the-Art Imaging for Detection and Staging of Cholangiocarcinoma? Oncologist, September 1, 2006; 11(8): 913 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Park, J. M. Lee, S. H. Kim, J. Y. Jeong, Y. J. Kim, K. H. Lee, S. H. Choi, J. K. Han, and B. I. Choi CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. Am. J. Roentgenol., August 1, 2006; 187(2): 445 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Kim, S. H. Kim, J. M. Lee, K. H. Lee, Y. J. Kim, S. K. An, A. Y. Jung, J. K. Han, and B. I. Choi Sonographic Features of an Intraductal Polypoid Mass: Differentiation Between Hepatocellular Carcinoma and Intraductal Cholangiocarcinoma J. Ultrasound Med., October 1, 2004; 23(10): 1283 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Choi, J. K. Han, S. T. Hong, and K. H. Lee Clonorchiasis and Cholangiocarcinoma: Etiologic Relationship and Imaging Diagnosis Clin. Microbiol. Rev., July 1, 2004; 17(3): 540 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lim, K.-H. Yoon, S. H. Kim, H. Y. Kim, H. K. Lim, S. Y. Song, and K. J. Nam Intraductal Papillary Mucinous Tumor of the Bile Ducts RadioGraphics, January 1, 2004; 24(1): 53 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lim Cholangiocarcinoma: Morphologic Classification According to Growth Pattern and Imaging Findings Am. J. Roentgenol., September 1, 2003; 181(3): 819 - 827. [Full Text] [PDF] |
||||
![]() |
J. H. Lim, M.-H. Kim, T. K. Kim, M.-G. Lee, S. S. Lee, J. W. Lee, K. T. Lee, J. K. Lee, and H. K. Lim Papillary Neoplasms of the Bile Duct That Mimic Biliary Stone Disease RadioGraphics, March 1, 2003; 23(2): 447 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Han, B. I. Choi, A. Y. Kim, S. K. An, J. W. Lee, T. K. Kim, and S.-W. Kim Cholangiocarcinoma: Pictorial Essay of CT and Cholangiographic Findings RadioGraphics, January 1, 2002; 22(1): 173 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Lee, H. K. Lim, K. M. Jang, S. H. Kim, S. J. Lee, J. H. Lim, and I. W. Choo Radiologic Spectrum of Cholangiocarcinoma: Emphasis on Unusual Manifestations and Differential Diagnoses RadioGraphics, October 1, 2001; 21(90001): S97 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Pannu, W. R. Maley, and E. K. Fishman Liver Transplantation: Preoperative CT Evaluation RadioGraphics, October 1, 2001; 21(90001): S133 - 146. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |